Kyle Treude

Kyle Treude serves as the Chief Growth Officer at Journey Biosciences, Inc. since July 2022 and is a Founding Partner at Diabetes Technology & Connectivity Consultants, LLC, where expertise lies in diabetes technology consulting focusing on continuous glucose monitoring and insulin therapies. Previous positions include Vice President of Worldwide Sales at Innova Medical Group, leading sales of SARS-CoV-2 Rapid Antigen Tests during the pandemic, and Vice President of Managed Care & Trade Relations at Valeritas, enhancing access and reimbursement strategies in the healthcare supply chain. Notably, Kyle Treude held various leadership roles at Dexcom, including Global Director of Corporate Accounts and National Director, US Distribution, where efforts significantly impacted continuous glucose monitoring technology sales. Educational qualifications include an MBA in Organizational Leadership from W. P. Carey School of Business and a Bachelor's Degree in Biological Sciences from UC Santa Barbara.